Co-careldopa (Carbidopa/levodopa) vs Botulinum toxin type A

National NHS prescribing compared (Prescription Cost Analysis)

Data updated March 2026

Co-careldopa (Carbidopa/levodopa) was dispensed 6,626.1× as often as Botulinum toxin type A in March 2026 — 132,521 items versus 20 in England.

132,521items

Co-careldopa (Carbidopa/levodopa) · March 2026

NHSBSA Prescription Cost Analysis

20items

Botulinum toxin type A · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Co-careldopa (Carbidopa/levodopa) versus Botulinum toxin type A: national items dispensed by month

▬ Co-careldopa (Carbidopa/levodopa) · ╌ Botulinum toxin type A

Source: NHSBSA Prescription Cost Analysis, to March 2026

Co-careldopa (Carbidopa/levodopa) versus Botulinum toxin type A, March 2026
Measure	Co-careldopa (Carbidopa/levodopa)	Botulinum toxin type A
Items, March 2026	132,521	20
Items, last 12 months	1,539,681	207
Net ingredient cost, March 2026	£1,154,956	£5,729